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http:WHAT THIS PAPER ADDS
Stroke is a complication of carotid revascularisation that limits the beneﬁt of the procedure in overall stroke
prevention. To decrease the risk of revascularisation it is important to understand the mechanism of stroke. In a
recent randomised trial in which patients were treated with carotid artery stenting (CAS) or carotid endarter-
ectomy (CEA), one-third of the procedural strokes were caused by periprocedural haemodynamic disturbances.
This suggests that careful attention to blood pressure control could lower the incidence of procedural stroke.Objective: To decrease the procedural risk of carotid revascularisation it is crucial to understand the mechanisms
of procedural stroke. This study analysed the features of procedural strokes associated with carotid artery
stenting (CAS) and carotid endarterectomy (CEA) within the International Carotid Stenting Study (ICSS) to identify
the underlying pathophysiological mechanism.
Materials and methods: Patients with recently symptomatic carotid stenosis (1,713) were randomly allocated to
CAS or CEA. Procedural strokes were classiﬁed by type (ischaemic or haemorrhagic), time of onset
(intraprocedural or after the procedure), side (ipsilateral or contralateral), severity (disabling or non-disabling),
and patency of the treated artery. Only patients in whom the allocated treatment was initiated were included.
The most likely pathophysiological mechanism was determined using the following classiﬁcation system: (1)
carotid-embolic, (2) haemodynamic, (3) thrombosis or occlusion of the revascularised carotid artery, (4)
hyperperfusion, (5) cardio-embolic, (6) multiple, and (7) undetermined.
Results: Procedural stroke occurred within 30 days of revascularisation in 85 patients (CAS 58 out of 791 and CEA
27 out of 819). Strokes were predominately ischaemic (77; 56 CAS and 21 CEA), after the procedure (57; 37 CAS
and 20 CEA), ipsilateral to the treated artery (77; 52 CAS and 25 CEA), and non-disabling (47; 36 CAS and 11 CEA).
Mechanisms of stroke were carotid-embolic (14; 10 CAS and 4 CEA), haemodynamic (20; 15 CAS and 5 CEA),
thrombosis or occlusion of the carotid artery (15; 11 CAS and 4 CEA), hyperperfusion (9; 3 CAS and 6 CEA), cardio-
embolic (5; 2 CAS and 3 CEA) and multiple causes (3; 3 CAS). In 19 patients (14 CAS and 5 CEA) the cause of stroke
remained undetermined.
Conclusion: Although the mechanism of procedural stroke in both CAS and CEA is diverse, haemodynamic
disturbance is an important mechanism. Careful attention to blood pressure control could lower the incidence of
procedural stroke.
 2015 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Stroke is a feared complication of carotid revascularisation
that limits the beneﬁt of the procedure in overall stroke
prevention. Large randomised clinical trials have shown that
patients treated with carotid artery stenting (CAS) have a
282 A. Huibers et al.higher risk of stroke within 30 days of intervention than
patients treated with carotid endarterectomy (CEA).1e4 This
difference in procedural stroke is mostly attributed to an
excess of minor non-disabling strokes. In these recent tri-
als1,4 the operative risk of CEA was signiﬁcantly lower than
the 7% risk of stroke or death within 30 days of treatment
reported in the North American Symptomatic Carotid End-
arterectomy Trial (NASCET) and the European Carotid Sur-
gery Trial (ECST).5,6 In contrast, mid- and long-term results
of these randomised trials show that the risk of stroke
beyond the operative period is similar between both
treatment arms.1e4,7,8 As a consequence, improvement in
surgical and stenting techniques to further decrease pro-
cedural stroke risks would clearly increase the absolute
beneﬁt of carotid revascularisation. The main suggested
causes of stroke related to carotid endarterectomy are
embolisation, intraoperative hypoperfusion, thrombotic
occlusion of the ipsilateral or contralateral carotid artery, or
hyperperfusion syndrome.9,10 The International Carotid
Stenting Study (ICSS) was a large randomised controlled
clinical trial that compared CAS and CEA in recently symp-
tomatic patients.1 Within ICSS, this study assessed the
clinical characteristics of the procedural strokes to better
understand the nature and mechanism of these adverse
events related to the revascularisation procedure.METHODS
Patient selection
The methods of ICSS (ISRCTN 25337470) have been
described previously.1,11 In summary, patients over 40 years
old with recently symptomatic moderate or severe carotid
stenosis (50% reduction of the lumen diameter), who
were considered equally suitable for either procedure, were
randomly allocated to undergo treatment by stenting or
endarterectomy. Patients were excluded if the stenosis was
considered unsuitable for stenting because of speciﬁc
vascular anatomy, if the stenosis was caused by non-
atherosclerotic disease, or if the symptomatic artery had
previously been revascularised. ICSS was approved by local
ethics committees for non-UK centres and by the Northwest
Multicentre Research Committee in the UK.Figure 1. Deﬁnition of intraprocedural vOutcome events
In ICSS major outcome events were adjudicated by an in-
dependent endpoint committee that was unaware of
treatment allocations. Stroke was deﬁned as a rapidly
developing clinical syndrome of focal disturbance of cerebral
function lasting more than 24 hours or leading to death with
no apparent cause other than that of vascular origin. Stroke
was considered procedural if the event occurred at any time
between initiation of the revascularisation (day 0) and day
30 after revascularisation. Stroke was classiﬁed as disabling if
there was an increase in the modiﬁed Rankin score to 3 or
more, attributable to the event 30 days after onset.
For the present analysis, the technical data forms
completed by the surgeon or interventionist at the time of
the procedure were reviewed along with the carotid and
brain imaging to determine the most likely mechanism of
stroke. The technical forms recorded the techniques used for
endarterectomy or stenting and also recorded complications
occurring during the procedure or immediately afterwards,
including complications such as hypotension or asystole. In
addition, the available clinical data describing the stroke
together with carotid and brain imaging were interrogated.
For procedures performed with the patient under general
anaesthesia, stroke was considered intraprocedural if the
cerebral deﬁcit presented before the patient fully emerged
from anaesthesia. Stroke was determined to have occurred
after the procedure if the onset of the stroke occurred after
full and asymptomatic awakening from anaesthesia including
a clear symptom-free interval between the intervention and
onset of symptoms. For procedures performed under local
anaesthesia, stroke was considered intraprocedural if the
cerebral deﬁcit was noticed in the intervention room during
the procedure and determined to have occurred after the
procedure if the patient left the intervention room before
the deﬁcit was noted (Fig. 1). If stroke occurred on the day of
the procedure and it was not possible to make the distinction
between intraprocedural or postprocedural, timing of stroke
was classiﬁed as undetermined.
Classiﬁcation of stroke mechanism
To determine the pathophysiological mechanism of proce-
dural stroke, a correlation was made between the onset ofersus postprocedural day 0 strokes.
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postprocedural haemodynamic complications, reported
technical difﬁculties, and observed carotid patency. The
topography of the procedural infarct (or haemorrhage) was
assessed using available brain imaging.
Two investigators (AH and DC) analysed separately all
available data described above to assess the likely proce-
dural stroke mechanism according to the pre-deﬁned
following classiﬁcation, in ischaemic stroke: (1) carotid-
embolic, (2) haemodynamic, (3) thrombosis or occlusion
of the carotid artery, (4) hyperperfusion, (5) cardio-embolic,
(6) multiple, or (7) undetermined. In haemorrhagic stroke, it
was determined whether stroke was related to: (1) hyper-
perfusion or (2) no hyperperfusion/ undetermined. For
cases of uncertainty or disagreement, an adjudication
meeting was held (AH, DC, FK, KRC-K, RLF, MMB, and TR)
where the mechanism was deﬁned by consensus or the
mechanism was classiﬁed as unknown (Appendix I).
Stroke mechanism was considered as “carotid embolic”
when there was angiographic evidence of an embolism or a
clear association with shunt insertion and the onset of
symptoms. Stroke mechanism was considered as “haemo-
dynamic” when there was intra or postprocedural brady-
cardia (a heart rate less than 40 beats perminute), or asystole
or any hypotension requiring treatment occurred. In the ICSS
study protocol, no pre-deﬁned cut-off blood pressure was
used to deﬁne hypo- and hypertension. After the procedure,
investigators were asked to provide information on the
occurrence of hypo- and hypertension requiring treatment,
but it was not mandatory to report actual blood pressure
values. The presence of a subcortical borderzone infarct,
deﬁned as an infarctmeasuringmore than 15mmormultiple
infarcts, regardless of size, in a Rosary-like pattern located (1)
in the corona radiata or (2) located between superﬁcial
systems of the middle cerebral artery and anterior cerebral
artery in the centrum semi-ovale area on the brain imaging
performed after procedural stroke, was considered to be an
indicator of a haemodynamic mechanism if the subcortical
borderzone infarct was not present on baseline brain imag-
ing. Where there was a haemodynamic infarct pattern, but
absence of a haemodynamic complication, strokes were
further assessed during the consensus meeting to conﬁrm
the haemodynamic mechanism. Stroke mechanism was
considered to be “thrombosis or occlusion of the carotid
artery”when the carotid artery was non-patent (deﬁned as a
 50% residual-stenosis or occlusion of the carotid) on im-
aging after procedural stroke or at re-exploration, irre-
spective of whether there was evidence for embolic or
haemodynamic mechanism. Arrhythmia was deﬁned as the
development of a new arrhythmia detected in the procedural
period. Stroke mechanism was determined as “cardio-
embolic” when atrial ﬁbrillation was detected on electro-
cardiogram immediately after stroke.Figure 2. Timing of strokes following CEA or CAS (CEA ¼ carotid
endarterectomy; CAS ¼ carotid artery stenting). The difference in
timings of event between CEA and CAS was statistically signiﬁcant
(p ¼ .014, chi-square test).Statistical analysis
A per-protocol analysis was performed including only pa-
tients randomised in ICSS in whom the allocated treatmentwas initiated as their ﬁrst ipsilateral revascularisation pro-
cedure. Patients were excluded who received the alterna-
tive revascularisation procedure as their ﬁrst treatment
(cross-over) or who received no revascularisation treat-
ment. Chi-square test was applied to compare frequencies
of procedural stroke characteristics, haemodynamic events
and technical difﬁculties between both treatment arms. A p
value of <.05 was considered to be statistically signiﬁcant.
RESULTS
Patient ﬂow
A total of 1,713 patients were enrolled in ICSS. For the
present per-protocol analysis, 791 patients were included
undergoing CAS and 819 undergoing CEA. A total of 85
patients suffered a procedural stroke, 58/791 (7.3%) pa-
tients assigned to the CAS arm and 27/819 (3.3%) patients
assigned to CEA.
Timing of stroke
In the stenting arm, 43 of 58 strokes (74%) occurred on the
day of the procedure (day 0). Twenty of the 58 (34%) were
assessed as intraprocedural strokes. In one (2%) patient the
onset of symptoms occurred on day 0, but it was not
possible to determine the exact timing of stroke. In the
surgery arm, 12 of 27 strokes (40%) occurred on the day of
the procedure. Five of the 27 (19%) were considered intra-
procedural, and for two (7%) strokes it was not possible to
identify the exact timing of stroke (Fig. 2). Among patients
assigned to the stenting arm, 15 of 58 strokes (26%) occurred
between day 1 and day 30, on day 1 (2); 2; 3; 4; 5; 6; 7 (2); 8;
10; 11; 13; 23; and 26, respectively. In the surgery arm, 15
out of 27 strokes (56%) occurred between day 1 and day 30,
on day 1 (4); 2 (2); 3 (3); 4; 5 (2); 6; 7; and 27, respectively.
Severity of stroke
Overall, most strokes were classiﬁed as non-disabling (47/85
[55%]) (Table 1). Non-disabling strokes were more
commonly seen in patients undergoing CAS (36/58 [62%])
compared with patients undergoing CEA (11/27 [41%])
(p ¼ .066). At day 0 of CAS, 28 of 43 (65%) strokes were
non-disabling. In the CEA arm, strokes on day 0 were non-
disabling in ﬁve of 12 (42%) patients and disabling or fatal
in seven of 12 (58%) patients (p ¼ .143).
Table 1. Number (%) of patients with various procedural stroke
characteristics among patients.
CAS
(N ¼ 58)
CEA
(N ¼ 27)
pb
Stroke type
Ischaemica 56 (97) 21 (78) .016
Haemorrhagic 2 (3) 5 (18)
Unknown 1 (4)
Arterial territory
Ipsilateral 52 (90) 25 (93) .965
Contralateral/vertebrobasilar 4 (7) 2 (7)
Unknown 2 (3)
Severity
Non-disabling 36 (62) 11 (41) .066
Fatal or disabling 22 (38) 16 (59)
CAS ¼ carotid artery stenting; CEA ¼ carotid endarterectomy.
a Two patients, both treated with CAS, had a retinal infarction and
were included in this category.
b p derived by use of the chi-square test comparing stroke type,
territory, and severity between CAS and CEA.
Table 2. Haemodynamic and technical difﬁculties among patients
with procedural stroke.
Total
(n ¼ 77)a
CAS
(n ¼ 55)
(intra vs.
after the
procedure)
CEA
(n ¼ 22)
(intra vs.
after the
procedure)
pb
Haemodynamics
- Hypertension 7 1 (0 vs. 1) 6 (1 vs. 5) .002
- Hypotension 13c 13 (10 vs. 3) 0 (0 vs. 0) .012
- New arrythmia 7 2 (1 vs. 1) 5 (2 vs. 3) .008
- Severe bradycardia 3 3 (3 vs. 0) 0 (0 vs. 0) .264
- No HD change 48 37 11 .158
Technical
difﬁculties
8 7 (5 vs. 2) 1 (1 vs. 0) .406
CAS ¼ carotid artery stenting; CEA ¼ carotid endarterectomy;
HD ¼ haemodynamic.
a Patients with missing data (8) were excluded from the analysis.
b One patient had both hypotension and severe bradycardia.
c p derived by use of chi-square test comparing haemodynamic
events and technical difﬁculties between CAS and CEA.
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Of the 55 patients in the CAS group, 18 (33%) developed
haemodynamic disturbances: hypotension (n ¼ 12), hy-
pertension (n ¼ 1), new arrhythmia (n ¼ 2), and severe
bradycardia (n ¼ 2) (Table 2). One patient developed both
hypotension and severe bradycardia. Among the 22 patients
in the CEA group, 11 patients (50%) developed haemody-
namic disturbances: hypertension (n ¼ 6) and new
arrhythmia (n ¼ 5). There were signiﬁcant differences be-
tween hypotension (p ¼ .012), hypertension (p ¼ .002), and
new arrhythmia (p ¼ .008) in the treatment arms. Among
patients treated with CAS who developed hypotension,
most (9 of 13 [69%]) were treated under local anaesthetics
without sedation. All patients treated with CEA who
developed hypertension were treated under general
anaesthesia (6/6 [100%]).
Technical difﬁculties
In eight patients, technical difﬁculties were encountered
during the procedure, of which seven were in the CAS arm.
In two patients either inability to advance the stent (1) or
displacement of the stent (1) occurred. A slow ﬂow or ﬁlling
defect was noted immediately after post-stenting balloon
dilatation, which correlated with the onset of neurological
symptoms in three patients. One CAS procedure was
considered to be technically difﬁcult because of the pres-
ence of a Bovine arch conﬁguration and a tortuous carotid
artery, resulting in a long procedure time and the require-
ment of an additional stent. In the remaining patient the
angioplasty balloon burst with extravasation of contrast and
acute onset of neurological symptoms. In the CEA arm, one
patient underwent a technically demanding procedure
because of a high lesion with a prolonged clamping time. All
eight strokes in procedures in which technical difﬁculties
were encountered, were ischaemic, and most occurred on
day 0 (7 of 8 [88%]) and were ipsilateral (7 of 8[88%]). The
occurrence of technical difﬁculties did not differ signiﬁ-
cantly between both treatment arms (p ¼ .406) (Table 2).For CAS patients intraprocedural control angiogram
revealed a residual stenosis in seven out of 58 (12%) pa-
tients with procedural stroke, compared with 93 out of 709
(13%) patients without a procedural stroke (p ¼ .820).
Patency of the carotid artery on post-stroke imaging
Among 85 patients, 79 (93%) had brain imaging after the
onset of the operative stroke. Post-stroke imaging of the
carotid arteries was performed within 30 days in only 36
patients (27/58 CAS and 9/27 CEA) (Appendix II). In these
36 patients, patency was assessed by Duplex ultrasound
(n ¼ 22), CTA (8), selective angiography (3), MRA (2), or
both US and CTA (1). Overall, in nine of 36 patients (25%; 6
CAS and 3 CEA) this revealed a > 50% residual stenosis and
in seven of 36 patients (19%; 5 CAS and 2 CEA) an occlusion
of the revascularised carotid artery. In the remaining 20
patients (56%; 16 CAS and 4 CEA) the carotid artery was
found to be fully patent. Three patients (CEA arm) were
reoperated at the onset of neurological symptoms. In two
patients re-exploration conﬁrmed a severe residual stenosis
and outcome of stroke was fatal (1) and non-disabling (1). In
one patient the carotid artery was found to be fully patent
and clear of thrombus or intimal ﬂap and outcome of stroke
was non-disabling. Follow-up with duplex ultrasonography
revealed a residual signiﬁcant (>50%) stenosis in ﬁve of 85
patients (6%; 3 CAS and 2 CEA) at 1-month follow-up.
Stroke mechanism
In 54 patients an obvious mechanism of stroke was deter-
mined. Based on the available information in the remaining
31 patients (22 CAS and 9 CEA), the adjudication committee
deﬁned the most likely mechanism in a further 12 patients
at the consensus meeting. Therefore, overall, the mecha-
nism of stroke was determined in 66 out of 85 patients
(77%). In 19 patients the cause of stroke remained unde-
termined, but the timing of stroke could be determined in
18 of these 19 patients. Six strokes (32%; 4 CAS and 2 CEA)
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after the procedure. In the remaining patient, the timing of
stroke was missing.
Of 66 patients (CAS 44 of 58 and CEA 22 of 27) with
determined stroke mechanism, in the patients undergoing
CAS, ischaemic stroke was caused by a haemodynamic
mechanism (n ¼ 15), carotid-embolism (10), or thrombosis
or occlusion of the carotid (11). Other causes of stroke were
hyperperfusion (2) or cardio-embolic (2). In three CAS pa-
tients multiple causes of stroke were identiﬁed: two patients
with both a haemodynamic and carotid-embolic cause, and
one patient with both thrombosis or occlusion of the carotid
artery and a haemodynamic cause. In patients undergoing
CEA, ischaemic stroke was caused by a haemodynamic
mechanism (n ¼ 5), followed by carotid-embolic (4), or
thrombosis or occlusion of the carotid (4). Within this sur-
gical treatment arm three ischaemic strokes were caused by
a cardio-embolism and another two by hyperperfusion.
There was no statistically signiﬁcant difference in ischaemic
stroke mechanism between both treatment arms (p¼ .479).
Among the seven haemorrhagic strokes, hyperperfusion was
found more often in the CEA arm (n¼ 4) compared with the
CAS arm (1). Overall, in 22 CEA patients with identiﬁed
stroke mechanism, six (6/22 ¼ 27%) had a postoperative
stroke caused by hyperperfusion.
There was a signiﬁcant difference in stroke mechanism
between CAS and CEA for day 0 strokes occurring after the
procedure (p ¼ .022). Overall, a trend was seen towards an
increased rate of carotid embolic and haemodynamic
mechanism on day 0. For days 1e30, there was a trend
towards an increased rate of thrombotic occlusion of the
carotid (Table 3). For both ischaemic and haemorrhagic
strokes there was no signiﬁcant difference in stroke mech-
anism between non-disabling and disabling strokes
(p ¼ .383; p ¼ .809).
The time interval between index event and procedure
was  14 days in 17/85 (20%) patients. Patients treated
within 2 weeks of the index event were more likely to
develop procedural stroke caused by a haemodynamic
mechanism compared with patients treated thereafter (8/
17 [47%] versus 12/68 [18%]; p ¼ .025).DISCUSSION
The present study describes clinical characteristics and
evaluates the cause of procedural strokes in symptomatic
patients with atherosclerotic carotid stenosis, undergoing
CAS or CEA in the International Carotid Stenting Study.This is
the ﬁrst detailed report of the most likely pathophysiological
mechanism of procedural stroke comparing both treatment
arms in patients treated either by CAS or CEA. In the CAS
group most strokes occurred on the day of the procedure,
were predominately minor, and most often caused by a
haemodynamic mechanism. Strokes after CEA occurredmore
frequently in the postoperative phase, were predominately
major, and most often caused by hyperperfusion.
Nearly all (97%) of the strokes associated with CAS were
the result of infarction. In contrast, in the surgery arm amuch larger proportion of patients (18%) suffered from a
haemorrhagic stroke. Haemorrhagic strokes are considered
a rare complication of carotid revascularisation but are
generally more severe than ischaemic strokes.12 Most
haemorrhagic strokes result from untreated postoperative
hypertension leading to hyperperfusion injury, especially in
patients with reestablishment of ﬂow in previously infarcted
cerebral tissue. Prolonged postoperative hypertension is
one of the most important risk factors for haemorrhagic
stroke after CEA.13 All haemorrhagic strokes in ICSS
occurred several days after the procedure and most were
preceded by severe hypertension. As a consequence, there
is an opportunity for prevention of these strokes with strict
postoperative blood pressure control.14 Given the delay in
haemorrhagic stroke onset after revascularisation and the
fact that hyperperfusion can complicate carotid revascu-
larisation up to several weeks after the procedure, it is
essential that the patient’s blood pressure be well
controlled before discharge. It might also be prudent to
arrange for any patient in whom there has been concern
about their blood pressure in the perioperative period to
have their blood pressure checked again soon after
discharge.
Nearly all strokes occurred in the ipsilateral hemisphere;
however, a few (6) developed in a cerebral territory not
directly related to the treated carotid artery. Non-ipsilateral
strokes can be addressed to catheter-related disruption of
the plaque in the aortic arch in patients undergoing CAS.15
The possible mechanism for non-ipsilateral strokes
following CEA is not always clear. In the present cohort,
three out of four non-ipsilateral strokes following CAS,
occurred on the day of the procedure, suggesting a
catheterisation-related mechanism. These ﬁndings are sup-
ported by the ICSS MRI substudy, in which patients treated
with CAS more often had a new ischaemic DWI lesion on
post-treatment scans.16
Timing of stroke relative to the postprocedural time in-
terval is of clinical importance in terms of understanding the
underlying mechanism of stroke. Therefore, a clear distinc-
tion was made between strokes that were apparent during
the procedure or at awakening versus those strokes that
occurred after a symptom-free interval. Cerebral deﬁcit
caused by carotid embolisation can occur intraprocedurally
when atherothrombotic debris is released spontaneously in
the unstable plaque or during manipulation of the carotid
plaque (stent insertion, dissection phase, shunt insertion,
and shunt dysfunction). Early postprocedural embolisation
may be caused by embolism formation on the endarterec-
tomised surface, a loose intimal ﬂap, or originate from the
external carotid artery. Very rarely, embolisation occurs in
the late postprocedural period.17 In the present cohort,
strokes caused by carotid embolism occurred in 85% on day
0. There was no signiﬁcant difference between carotid
embolic events in the treatment arms, although the abso-
lute numbers of strokes were signiﬁcantly greater on day
0 after CAS.
In the CAS arm, stroke was most often caused by a
haemodynamic mechanism. Intraprocedural uncontrolled
Table 3. Stroke mechanism according to the procedural time interval.a
Day 0,
intraprocedural
(n ¼ 25)
Day 0, after the
procedure
(n ¼ 27)
Days 1e30
(n ¼ 23)
CAS CEA CAS CEA CAS CEA
n ¼ 20 n ¼ 5 n ¼ 22 n ¼ 5 n ¼ 13 n ¼ 10
Ischaemic
- Carotid-embolic 4 (20) 0 (0) 5 (23) 2 (40) 0 (0) 2 (20)
- Haemodynamic 6 (30) 3 (60) 8 (36) 0 (0) 1 (8) 2 (20)
- Thrombosis or occlusion of the carotid artery 2 (10) 0 (0) 2 (9) 1 (20) 7 (54) 2 (20)
- Hyperperfusion 1 (5) 0 (0) 1 (5) 0 (0) 0 (0) 2 (20)
- Cardio-embolic 1 (5) 0 (0) 0 (0) 2 (40) 1 (8) 1 (10)
- Multiple 2 (10) 0 (0) 0 (0) 0 (0) 1 (8) 0 (0)
- Undetermined 4 (20) 2 (40) 6 (27) 0 (0) 3 (23) 1 (10)
p ¼ .654b p ¼ .022 p ¼ .181
Day 0,
intraprocedural
(n ¼ 0)
Day 0, after the
procedure
(n ¼ 0)
Days 1e30
(n ¼ 7)
CAS CEA CAS CEA CAS CEA
n ¼ 0 n ¼ 0 n ¼ 0 n ¼ 0 n ¼ 2 n ¼ 5
Haemorrhagic
- Hyperperfusion 0 (0) 0 (0) 0 (0) 0 (0) 1 (50) 4 (80)
- No hyperperfusion/undetermined 0 (0) 0 (0) 0 (0) 0 (0) 1 (50) 1 (20)
p ¼ .427
CAS ¼ carotid artery stenting; CEA ¼ carotid endarterectomy.
a The three strokes with unknown timing are not included in the table. In these cases the mechanism was carotid-embolic (1), thrombosis
or occlusion of the carotid artery (1), and undetermined (1).
b p derived by use of chi-square test comparing stroke mechanism (on, respectively, day 0, intraprocedural, day 0 after the procedure, and
days 1e30) between CAS and CEA.
286 A. Huibers et al.hypotension is a well-recognised and feared cause of ce-
rebral deﬁcit in patients undergoing carotid intervention.18
Haemodynamic depression is likely to result from manipu-
lation of the carotid sinus and baroreceptor dysfunction.19
Other reasons for intraprocedural hypoperfusion are difﬁ-
culty placing the shunt, prolonged clamping (CEA), or
balloon dilation (CAS). In the present cohort, the proportion
of haemodynamic strokes did not differ signiﬁcantly be-
tween CAS and CEA, although the absolute numbers were
again higher in the CAS arm. This is in keeping with earlier
observations showing that the decrease in blood pressure in
the ﬁrst days after carotid intervention is greater in patients
treated with CAS than CEA.20 Strict control of blood pres-
sure also seems to be necessary during the weeks after CEA
to avoid reperfusion syndrome.
Thrombosis or occlusion of the carotid artery has been
described as a common cause of early postprocedural
stroke after carotid intervention.21 Most thrombotic occlu-
sions in the early postprocedural period have been sug-
gested to be caused by technical errors during intervention
and therefore can be corrected with re-establishment of
cerebral perfusion.22 In the present cohort, patency of the
carotid artery was assessed in only 36 of 85 patients, which
revealed a residual stenosis or occlusion in 44% (16 of 36). It
is possible that some of the patients in whom no post-
stroke imaging of the carotid was performed might have
beneﬁtted from re-intervention.
This study has several limitations. First of all, because
of its retrospective character it was not possible toidentify the exact timing of stroke in three patients.
Secondly, in ICSS no standard neurological assessment by
a stroke physician or neurologist was performed until 1-
month post revascularisation, although patients were
seen by physicians earlier than 1 month post revascular-
isation if they suffered from a procedural stroke. As a
consequence, minor signs and symptoms of cerebral
deﬁcit could have been missed. Third, in 19 of 85 patients,
it was not possible to conclude on the underlying
mechanism of stoke. Therefore, within this relatively small
study population, caution must be applied to the validity
of the proposed stroke mechanism in the remaining 66
cases. However, most of these strokes occurred on day 0,
reafﬁrming the importance of thorough technique and
close patient monitoring during the procedure and in the
early postprocedural period. Fourth, in this post-hoc
analysis the interpretation of available study data was
necessary to deﬁne the most likely mechanism of stroke.
Finally, analysis on the occurrence of hypo- and hyper-
tension was based on the judgement of the physician that
these events required treatment. Therefore, it was not
possible to make a ﬁrm recommendation on threshold
values for peri-procedural blood pressure. Additional
studies are required to establish guidelines for the man-
agement of haemodynamic instability in the peri-
procedural period. Further, in future studies and to
allow comparison and pooling of data, it will be important
to score procedural strokes according to the same method
used in the present study.
Mechanism of Procedural Stroke Following Carotid Revascularisation 287CONCLUSION
The mechanism of stroke following carotid intervention is
diverse and haemodynamic disturbance is an important
mechanism both in CAS and CEA. Blood pressure control
requires careful attention in the peri-procedural period,
which can potentially lower the incidence of procedural
stroke. Further knowledge on the role of hypotension dur-
ing stenting and the role of hypertension following surgery
is required to further reduce procedural-related events of
carotid revascularisation.CONFLICT OF INTEREST
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Kinking of a Superior Mesenteric Artery Stent due to Contraction
of the Abdominal Wall
Paul van Schaik *, Raechel Toorop
University Medical Center Utrecht, Vascular Surgery, Heidelberglaan 100, 3584CX Utrecht, The Netherlandsout contraction of the abdominal wall. (Right) Kinking of a superiorA 79 year old man, treated 3 years previously for mesente
artery (SMA), presented in the emergency room with abdominal pain, nausea, and vomiting of 3 days’ duration. Anric ischemia with stent placement in the superior mesenteric
abdominal computed tomography angiogram was performed, which indicated sigmoid colitis. By chance, a kink of the SMA
stent was noted, with contraction of the abdominal wall. There was no in-stent stenosis and the inferior mesenteric artery
was open. After 24 hours without oral intake the patient was symptom free, and a colonoscopy conﬁrmed the diagnosis of
colitis.
